Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KRMDthis companyKORU Medical Systems, Inc.	$3.13	-101.75×	15.74×	6.52×	-145.65×	-428.1%	62.3%	-7.2%	-6.4%	-15.5%	-14.5%	-0.2%	0.21×	2.98×	0×	2.44×	0.0%	5	8.89	1	C-
HINDVyome Holdings, Inc.	$1.59	-0.72×	3.04×	23.26×	-0.24×	16.7%	64.7%	-859.2%	-3209.7%	-420.2%	-72.4%	-50.4%	0.01×	0.48×	-18.73×	1.99×	0.0%	3	-13.32	3	B-
INFUInfuSystem Holdings, Inc.	$14.83	28.03×	3.23×	1.29×	7.36×	-55.8%	56.0%	8.3%	4.6%	11.6%	9.3%	8.5%	0.06×	0.01×	9.18×	1.8×	0.0%	9	5.73	3	B+
MXCTMaxCyte, Inc.	$1.32	-3.69×	0.96×	4.99×	-4.12×	-318.7%	81.2%	-137.1%	-135.1%	-26.0%	-23.9%	-21.9%	0.1×	0.05×	0×	8.3×	0.0%	2	1.18	2	C+
OSUROraSure Technologies, Inc.	$3.60	-2.57×	0.52×	1.55×	0.15×	-91.8%	41.9%	-59.2%	-59.8%	-20.2%	-18.6%	-29.9%	0.04×	3.28×	0×	6.58×	0.0%	5	—	2	B-
STIMNeuronetics, Inc.	$2.21	-2.34×	4.07×	0.61×	-5.43×	-2045.6%	48.5%	-21.1%	-26.1%	-174.3%	-27.0%	-23.3%	4.04×	-2.07×	-3.74×	2.02×	0.0%	4	-3.06	2	C
Peer median	—	-2.34×	3.04×	1.55×	-0.24×	-91.8%	56.0%	-59.2%	-59.8%	-26.0%	-23.9%	-23.3%	0.06×	0.05×	0×	2.02×	0.0%	4	-0.94	2	—